Academic Journal
Geroscience insights into difficult-to-treat rheumatoid arthritis: the role of unhealthy aging, comorbidity, and therapeutic complexity.
| Τίτλος: | Geroscience insights into difficult-to-treat rheumatoid arthritis: the role of unhealthy aging, comorbidity, and therapeutic complexity. |
|---|---|
| Συγγραφείς: | Lehoczki A; Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.; Fodor Center for Prevention and Healthy Aging, Semmelweis University, Budapest, Hungary.; Doctoral College, Health Sciences Division, Semmelweis University, Budapest, Hungary., Ungvari Z; Vascular Cognitive Impairment, Neurodegeneration, and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; International Training Program in Geroscience, Doctoral College/Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary., Szappanos Á; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.; Department of Rheumatology and Immunology, Semmelweis University, Budapest, Hungary., Fekete M; Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.; Fodor Center for Prevention and Healthy Aging, Semmelweis University, Budapest, Hungary., Gunkl-Tóth L; Department of Rheumatology and Immunology, Semmelweis University, Budapest, Hungary.; Department of Pharmacology and Pharmacotherapy, University of Pécs Medical School, Pécs, Hungary.; HUN-REN Chronic Pain Research Group, Pécs, Hungary., Nagy G; Heart and Vascular Center, Semmelweis University, Budapest, Hungary. nagy.gyorgy2@semmelweis.hu.; Department of Rheumatology and Immunology, Semmelweis University, Budapest, Hungary. nagy.gyorgy2@semmelweis.hu.; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary. nagy.gyorgy2@semmelweis.hu. |
| Πηγή: | GeroScience [Geroscience] 2026 Apr; Vol. 48 (2), pp. 2153-2177. Date of Electronic Publication: 2025 Dec 27. |
| Τύπος έκδοσης: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Cham : Springer International Publishing, [2017]- |
| Ιατρικοί όροι (MeSH): | Arthritis, Rheumatoid*/immunology , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/therapy , Arthritis, Rheumatoid*/epidemiology , Aging*/immunology , Geroscience*, Antirheumatic Agents/therapeutic use ; Humans ; Comorbidity ; Aged ; Immunosenescence |
| Περίληψη: | Difficult-to-treat rheumatoid arthritis (D2T RA) is an emerging challenge in aging populations, where disease persistence and therapeutic failure often reflect not only autoimmune dysregulation but also the cumulative effects of age-related biological changes across multiple organ systems. This review reframes D2T RA through the lens of geroscience, highlighting how immunosenescence, inflammaging, and organ system vulnerability converge to create a treatment-resistant disease phenotype. Age-associated alterations in adaptive and innate immunity-such as diminished T cell diversity, impaired regulatory function, expansion of age-associated B cells, and heightened inflammasome activation-closely intersect with the immunopathogenesis of RA. The potential contribution of clonal hematopoiesis of indeterminate potential (CHIP) to systemic inflammation and myeloid dysfunction is also discussed as a novel mechanistic link. In parallel, aging of the musculoskeletal system magnifies joint damage, sarcopenia, and pain sensitization. Furthermore, advancing age is also accompanied by multimorbidity, polypharmacy, and frailty, which in turn constrain therapeutic options and increase the risk of adverse events. We argue that D2T RA in the elderly should not be viewed in isolation, but as part of a broader syndemic of age-related diseases driven by shared inflammatory and metabolic pathways. This perspective calls for a shift toward integrated, individualized care strategies that balance efficacy, safety, and quality of life. Future directions include the development of age-adapted treatment guidelines, expanded inclusion of older adults in clinical trials, and the application of artificial intelligence and machine learning to predict high-risk trajectories and personalize management. A geroscience-informed approach offers the conceptual foundation to meet the growing complexity of RA care in aging populations. (© 2025. The Author(s).) |
| Competing Interests: | Declarations. Ethics approval and consent to participate: N/A. Consent for publication: N/A. Competing interests: Dr. Zoltan Ungvari serves as Editor-in-Chief for GeroScience. All other authors declare no competing interests. |
| References: | Autoimmun Rev. 2023 Nov;22(11):103423. (PMID: 37634676) J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1):. (PMID: 37698382) Immune Netw. 2016 Dec;16(6):322-329. (PMID: 28035207) Ann Rheum Dis. 2025 May;84(5):664-679. (PMID: 40037995) Musculoskeletal Care. 2007 Dec;5(4):175-90. (PMID: 17623274) Ann Rheum Dis. 2016 Jan;75(1):3-15. (PMID: 25969430) Arthritis Res Ther. 2021 Jan 7;23(1):16. (PMID: 33413603) Cell Biochem Funct. 2024 Jun;42(4):e4025. (PMID: 38845083) Ann Rheum Dis. 2021 Jan;80(1):31-35. (PMID: 33004335) Neural Plast. 2017;2017:9724371. (PMID: 28706741) Ann Rheum Dis. 2007 Apr;66(4):476-80. (PMID: 17114192) ARP Rheumatol. 2022 Feb 27;1(3):225-229. (PMID: 35724450) Int J Mol Sci. 2022 Aug 05;23(15):. (PMID: 35955873) Ann Rheum Dis. 2017 Jan;76(1):17-28. (PMID: 27697765) Annu Rev Pathol. 2010;5:99-118. (PMID: 20078217) Biochem Biophys Rep. 2025 May 05;42:102038. (PMID: 40417081) Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):28-30. (PMID: 15852252) Ageing Res Rev. 2022 May;77:101596. (PMID: 35219904) Semin Arthritis Rheum. 2020 Apr;50(2):266-275. (PMID: 31761290) J Clin Med. 2021 Aug 13;10(16):. (PMID: 34441861) J Clin Med. 2025 Feb 10;14(4):. (PMID: 40004668) J Rheumatol. 2010 May;37(5):911-6. (PMID: 20231200) Arthritis Rheumatol. 2024 May;76(5):667-669. (PMID: 37984460) J Am Coll Cardiol. 2023 May 23;81(20):1996-2009. (PMID: 37197843) Ann Rheum Dis. 2022 Nov;81(11):1504-1514. (PMID: 35760450) Cochrane Database Syst Rev. 2011 Nov 09;(11):CD008920. (PMID: 22071859) Arthritis Care Res (Hoboken). 2024 May;76(5):627-635. (PMID: 38116680) Autoimmunity. 2025 Dec;58(1):2473741. (PMID: 40035723) Clin Rheumatol. 2021 Dec;40(12):4869-4877. (PMID: 34283332) Nat Commun. 2021 Feb 10;12(1):907. (PMID: 33568645) Arthritis Rheum. 1995 May;38(5):649-54. (PMID: 7538295) Cell. 2025 Apr 17;188(8):2043-2062. (PMID: 40250404) J Rheumatol. 2016 Aug;43(8):1469-74. (PMID: 27252422) Front Glob Womens Health. 2025 Jun 05;6:1534447. (PMID: 40538914) J Clin Rheumatol. 2025 Jun 1;31(4):142-148. (PMID: 39760446) Rheumatology (Oxford). 2011 Feb;50(2):252-60. (PMID: 20837497) Autoimmun Rev. 2020 Jun;19(6):102528. (PMID: 32234572) Cell Mol Gastroenterol Hepatol. 2025;19(2):101423. (PMID: 39461590) J Clin Invest. 2024 Oct 1;134(19):. (PMID: 39352379) Z Rheumatol. 2018 Mar;77(2):160-167. (PMID: 27644953) Rheumatol Int. 2018 Jun;38(6):1031-1041. (PMID: 29651539) Sci Transl Med. 2025 Mar 26;17(791):eadq1735. (PMID: 40138455) J Rheumatol. 2023 Oct 1;:. (PMID: 37778763) JAMA Cardiol. 2021 Sep 1;6(9):1069-1077. (PMID: 34106216) Front Physiol. 2020 Jun 24;11:592. (PMID: 32670080) BMC Geriatr. 2025 Jul 30;25(1):564. (PMID: 40739540) J Clin Med. 2024 Dec 13;13(24):. (PMID: 39768516) Xenobiotica. 2014 Dec;44(12):1108-16. (PMID: 24947446) Circ Res. 2018 Sep 14;123(7):773-786. (PMID: 30355081) Clin Rheumatol. 2024 May;43(5):1421-1433. (PMID: 38499817) Cell. 2024 Jul 11;187(14):3690-3711.e19. (PMID: 38838669) Arthritis Res Ther. 2011 Apr 28;13(2):211. (PMID: 21542893) Mod Rheumatol. 2023 Jul 4;33(4):723-731. (PMID: 35920411) Nat Cardiovasc Res. 2023 Jun;2(6):572-586. (PMID: 37539077) Autoimmun Rev. 2024 May;23(5):103539. (PMID: 38582291) Pathol Oncol Res. 2024 Feb 23;30:1611623. (PMID: 38463143) Nat Immunol. 2021 Jan;22(1):10-18. (PMID: 33257900) Front Immunol. 2017 Mar 20;8:300. (PMID: 28373873) J Psychosoc Nurs Ment Health Serv. 2009 Oct;47(10):15-6, 17-8. (PMID: 19835315) Antioxidants (Basel). 2022 Jun 12;11(6):. (PMID: 35740048) Rheumatology (Oxford). 2022 Aug 30;61(9):3552-3566. (PMID: 35238332) Rheumatol Int. 2025 Jun 9;45(6):152. (PMID: 40488895) Immunol Rev. 2005 Jun;205:147-57. (PMID: 15882351) BMC Pharmacol Toxicol. 2024 Feb 1;25(1):13. (PMID: 38303016) J Acad Nutr Diet. 2024 Nov;124(11):1451-1473. (PMID: 39025233) Mediators Inflamm. 2020 Sep 12;2020:2076328. (PMID: 33005097) Lancet Rheumatol. 2025 Apr;7(4):e274-e289. (PMID: 39848270) Front Pharmacol. 2023 Oct 10;14:1199031. (PMID: 37881181) PLoS One. 2025 Jan 16;20(1):e0317364. (PMID: 39820552) JACC Basic Transl Sci. 2024 Apr 08;9(4):522-534. (PMID: 38680957) Int J Rheum Dis. 2016 Jun;19(6):536-50. (PMID: 26200188) Ann Rheum Dis. 2023 Jan;82(1):3-18. (PMID: 36357155) Front Immunol. 2021 Apr 02;12:652771. (PMID: 33868292) Biomed Res Int. 2013;2013:916530. (PMID: 23971049) Expert Opin Drug Metab Toxicol. 2020 Jul;16(7):617-626. (PMID: 32500745) Rheumatology (Oxford). 2019 Oct 1;58(10):1767-1776. (PMID: 30982886) Rheumatol Int. 2015 Mar;35(3):445-58. (PMID: 25543267) Blood Cancer J. 2018 Jul 26;8(8):69. (PMID: 30061683) Nat Genet. 2009 Dec;41(12):1313-8. (PMID: 19898481) ACR Open Rheumatol. 2019 Jul 28;1(6):366-372. (PMID: 31777816) Nat Med. 2024 Feb;30(2):360-372. (PMID: 38355974) Nat Commun. 2023 Jul 20;14(1):4394. (PMID: 37474626) PLoS Biol. 2020 Jan 16;18(1):e3000599. (PMID: 31945054) Int J Rheum Dis. 2025 Apr;28(4):e70239. (PMID: 40269471) J Rheumatol. 1997 Oct;24(10):1903-9. (PMID: 9330930) J Pain Res. 2016 Mar 14;9:137-46. (PMID: 27042139) Ther Adv Musculoskelet Dis. 2019 Jul 30;11:1759720X19844632. (PMID: 31431810) Arthritis Res Ther. 2023 May 20;25(1):85. (PMID: 37210569) Front Immunol. 2025 May 22;16:1585895. (PMID: 40475761) Ann Rheum Dis. 2025 Apr;84(4):643-652. (PMID: 39739386) Arthritis Care Res (Hoboken). 2024 Sep;76(9):1287-1293. (PMID: 38682605) Int Immunopharmacol. 2025 Nov 14;165:115518. (PMID: 40925204) Autoimmun Rev. 2022 Jan;21(1):102925. (PMID: 34454117) Aging Dis. 2023 Jun 1;14(3):592-604. (PMID: 37191424) Semin Arthritis Rheum. 1997 Jun;26(6):794-804. (PMID: 9213378) J Autoimmun. 2023 May;137:102947. (PMID: 36357240) Front Immunol. 2025 Apr 30;16:1584023. (PMID: 40370449) J Rheumatol. 2024 Aug 1;51(8):752-758. (PMID: 38692670) J Pharm Pract. 2021 Jun;34(3):365-371. (PMID: 31451091) Nat Rev Rheumatol. 2024 Aug;20(8):455. (PMID: 38906979) Microorganisms. 2023 Aug 28;11(9):. (PMID: 37764014) Drugs Aging. 2011 May 1;28(5):379-90. (PMID: 21542660) BMJ. 2024 Oct 28;387:e079830. (PMID: 39467592) Cytokine. 2024 Dec;184:156762. (PMID: 39326197) Arthritis Rheumatol. 2024 Mar;76(3):351-353. (PMID: 37961826) Ann Rheum Dis. 2022 Jan;81(1):20-33. (PMID: 34407926) Curr Aging Sci. 2015;8(2):131-46. (PMID: 26212057) Hematol Oncol. 2018 Dec;36(5):733-739. (PMID: 29862535) Signal Transduct Target Ther. 2023 May 13;8(1):200. (PMID: 37179335) RMD Open. 2020 Jun;6(2):. (PMID: 32506054) Curr Opin Rheumatol. 2023 May 1;35(3):170-174. (PMID: 36795021) Gastroenterol Hepatol. 2021 Oct;44(8):587-598. (PMID: 33640469) Arthritis Rheumatol. 2025 Jul;77(7):792-804. (PMID: 39800938) Rheumatology (Oxford). 2022 Feb 2;61(2):713-722. (PMID: 33930113) Rheumatology (Oxford). 2021 Oct 2;60(10):4591-4597. (PMID: 33470401) Sci Rep. 2024 May 14;14(1):11061. (PMID: 38745032) Arthritis Res Ther. 2008;10(2):R30. (PMID: 18325087) Rheumatology (Oxford). 2025 Jul 1;64(7):4172-4180. (PMID: 39928358) Clin Rheumatol. 2019 Oct;38(10):2909-2915. (PMID: 31187337) Nat Immunol. 2021 Dec;22(12):1551-1562. (PMID: 34811544) Womens Midlife Health. 2019 Aug 9;5:3. (PMID: 31417683) Br J Community Nurs. 2022 May 2;27(5):232-241. (PMID: 35522453) Clin Exp Immunol. 2023 Mar 24;211(3):208-223. (PMID: 36420636) Front Aging. 2025 May 14;6:1452917. (PMID: 40438731) Arthritis Rheum. 1997 Jun;40(6):1106-14. (PMID: 9182921) Rheumatol Int. 2012 Nov;32(11):3397-403. (PMID: 22057136) Sci Adv. 2025 May 2;11(18):eadt9846. (PMID: 40305610) J Inflamm Res. 2024 Dec 27;17:11631-11657. (PMID: 39741752) Rheumatol Int. 2025 Feb 08;45(3):44. (PMID: 39921727) Microbiome. 2025 Apr 02;13(1):91. (PMID: 40176137) Genes Dev. 2025 Aug 1;39(15-16):923-925. (PMID: 40645668) J Intensive Care Med. 2021 Jul;36(7):766-774. (PMID: 32249644) J Clin Rheumatol. 2015 Oct;21(7):349-54. (PMID: 26398461) Front Pharmacol. 2020 Nov 26;11:523962. (PMID: 33390933) Stem Cell Res Ther. 2021 Sep 14;12(1):502. (PMID: 34521481) Mod Rheumatol. 2024 Oct 15;34(6):1095-1102. (PMID: 38511322) Front Aging. 2022 Apr 25;3:867950. (PMID: 35821833) J Clin Invest. 2013 Mar;123(3):966-72. (PMID: 23454759) Cell Metab. 2020 Dec 1;32(6):967-980.e5. (PMID: 33264602) Front Med (Lausanne). 2020 Nov 19;7:573542. (PMID: 33330531) JAMA Cardiol. 2020 Oct 1;5(10):1170-1175. (PMID: 32639511) Arthritis Res Ther. 2025 Jul 9;27(1):141. (PMID: 40635060) Aging Cell. 2022 Sep;21(9):e13700. (PMID: 36000805) Clin Rheumatol. 2023 Sep;42(9):2287-2295. (PMID: 37243802) J Clin Invest. 1996 May 1;97(9):2027-37. (PMID: 8621791) Pain. 2023 Mar 1;164(3):e122-e134. (PMID: 36017880) J Gerontol A Biol Sci Med Sci. 2024 Mar 1;79(3):. (PMID: 37982669) Geroscience. 2025 Feb;47(1):703-720. (PMID: 39405013) Int Urol Nephrol. 2020 Jan;52(1):147-154. (PMID: 31820358) Mediterr J Rheumatol. 2022 Dec 31;33(4):394-406. (PMID: 37034365) Exp Gerontol. 2024 Oct 1;195:112546. (PMID: 39153533) BMC Rheumatol. 2023 Sep 8;7(1):28. (PMID: 37684705) J Rheumatol. 2018 Oct;45(10):1361-1366. (PMID: 29907672) Arthritis Res Ther. 2025 Apr 05;27(1):80. (PMID: 40188149) Reumatologia. 2023;61(6):481-491. (PMID: 38322106) J Clin Rheumatol. 2014 Mar;20(2):61-7. (PMID: 24561407) ACR Open Rheumatol. 2025 Aug;7(8):e70066. (PMID: 40728088) Rheumatology (Oxford). 2019 Oct 1;58(10):1755-1766. (PMID: 30982883) Clin Pharmacokinet. 2025 Mar;64(3):335-367. (PMID: 39798015) Ann Rheum Dis. 2010 Apr;69(4):631-7. (PMID: 20215140) Muscle Nerve. 2009 Jun;39(6):866-70. (PMID: 19373885) Rheumatology (Oxford). 2023 May 2;62(5):1773-1779. (PMID: 36205537) Nat Commun. 2024 Sep 4;15(1):7712. (PMID: 39231947) Immunology. 1993 Sep;80(1):96-102. (PMID: 7503950) JAMA. 2025 Sep 9;334(10):894-907. (PMID: 40587168) Circulation. 2024 Apr 30;149(18):1419-1434. (PMID: 38357791) Expert Opin Drug Metab Toxicol. 2024 Aug;20(8):741-748. (PMID: 38916236) Methods Mol Biol. 2022;2547:527-567. (PMID: 36068476) Clin Exp Rheumatol. 2022 Nov;40(11):2179-2187. (PMID: 36135939) Nat Rev Rheumatol. 2014 Oct;10(10):581-92. (PMID: 24861185) Front Immunol. 2020 Oct 29;11:576134. (PMID: 33193369) BMC Rheumatol. 2022 Dec 26;6(1):90. (PMID: 36567352) Exp Gerontol. 2025 Sep;208:112828. (PMID: 40651670) Pharmacogenomics. 2020 Nov;21(16):1151-1156. (PMID: 33124499) Nat Metab. 2022 Jun;4(6):759-774. (PMID: 35739396) Rheumatol Int. 2020 Nov;40(11):1891-1894. (PMID: 32322981) Arthritis Res Ther. 2003;5(4):R210-3. (PMID: 12823856) N Engl J Med. 2017 Jul 13;377(2):111-121. (PMID: 28636844) Curr Rheumatol Rep. 2025 Mar 18;27(1):21. (PMID: 40100461) Immun Ageing. 2020 Mar 9;17:6. (PMID: 32190092) Cell Immunol. 2022 Jul;377:104533. (PMID: 35594728) Arterioscler Thromb Vasc Biol. 2023 May;43(5):774-783. (PMID: 36951061) Clin Rheumatol. 2025 Mar;44(3):1019-1029. (PMID: 39841373) Rheumatology (Oxford). 2025 Jan 1;64(1):65-73. (PMID: 39383505) BMC Rheumatol. 2025 May 26;9(1):61. (PMID: 40420239) Curr Opin Rheumatol. 2016 May;28(3):330-6. (PMID: 26986246) Inflammation. 2025 Aug;48(4):1811-1827. (PMID: 39414673) Clin Pharmacokinet. 1988 Nov;15(5):287-94. (PMID: 3203484) Ecotoxicol Environ Saf. 2025 Sep 01;302:118557. (PMID: 40561603) Stroke. 2023 Apr;54(4):938-946. (PMID: 36789775) Clin Epigenetics. 2025 Jul 2;17(1):111. (PMID: 40605113) Ann Rheum Dis. 2018 Dec;77(12):1705-1709. (PMID: 30194273) PLoS One. 2019 Nov 8;14(11):e0224632. (PMID: 31703070) Rheumatol Immunol Res. 2022 Oct 20;3(3):128-135. (PMID: 36788975) Mod Rheumatol. 2024 Aug 20;34(5):892-899. (PMID: 38491996) Atherosclerosis. 2020 Mar;297:120-126. (PMID: 32109665) Mod Rheumatol. 2025 Apr 8;35(3):597-598. (PMID: 39780517) Blood. 2021 Nov 25;138(21):2093-2105. (PMID: 34125889) Cell Metab. 2016 Feb 9;23(2):303-14. (PMID: 26686024) Joint Bone Spine. 2022 Jul;89(4):105343. (PMID: 35033680) Arthritis Res Ther. 2010;12(1):R5. (PMID: 20064207) J Pain. 2009 Mar;10(3):300-5. (PMID: 19070549) J Intern Med. 2025 Jun;297(6):642-656. (PMID: 40062693) Int Immunopharmacol. 2025 Mar 06;149:114164. (PMID: 39904033) J Clin Lab Anal. 2020 May;34(5):e23188. (PMID: 31907973) Interact J Med Res. 2025 May 23;14:e64456. (PMID: 40407708) Stroke. 2022 Mar;53(3):788-797. (PMID: 34743536) J Biomed Sci. 2021 Mar 3;28(1):15. (PMID: 33658022) Clin Rheumatol. 2023 Aug;42(8):2069-2077. (PMID: 37211570) Lancet. 2015 Jul 18;386(9990):258-65. (PMID: 25975452) Medicina (Kaunas). 2024 Jul 17;60(7):. (PMID: 39064585) ACR Open Rheumatol. 2025 Mar;7(3):e70013. (PMID: 40035233) RMD Open. 2024 Apr 12;10(2):. (PMID: 38609319) Drugs Aging. 2025 May;42(5):413-433. (PMID: 40202700) Front Med (Lausanne). 2022 Aug 29;9:991677. (PMID: 36106320) Clin Ther. 2019 Jul;41(7):1246-1255. (PMID: 31196641) Nat Commun. 2023 Aug 19;14(1):5038. (PMID: 37598227) Mod Rheumatol. 2016;26(3):331-5. (PMID: 26374955) Circ Res. 2018 Feb 2;122(3):523-532. (PMID: 29420212) Arthritis Res Ther. 2025 May 8;27(1):101. (PMID: 40340864) Cochrane Database Syst Rev. 2012 Jan 18;1:CD008922. (PMID: 22258993) Life Sci. 2020 Aug 1;254:117734. (PMID: 32380080) Arthritis Care Res (Hoboken). 2025 Nov;77(11):1368-1373. (PMID: 40452358) Int J Gen Med. 2024 Dec 06;17:5859-5868. (PMID: 39659512) Nutrients. 2021 Jun 29;13(7):. (PMID: 34209676) Medicina (Kaunas). 2023 Oct 23;59(10):. (PMID: 37893596) Clin Exp Immunol. 2025 Jan 21;219(1):. (PMID: 40336246) Nat Rev Immunol. 2017 Mar;17(3):208-214. (PMID: 28163301) Geriatr Gerontol Int. 2022 May;22(5):399-404. (PMID: 35365932) Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9203-8. (PMID: 10922071) Rheumatology (Oxford). 2019 May 1;58(5):748-764. (PMID: 29982766) Front Immunol. 2018 Feb 01;9:95. (PMID: 29472917) Epidemiology. 2017 Oct;28 Suppl 1:S54-S59. (PMID: 29028676) Clin Immunol. 2007 May;123(2):209-18. (PMID: 17317320) Rheumatol Ther. 2021 Mar;8(1):599-607. (PMID: 33484433) J Pain Palliat Care Pharmacother. 2021 Dec;35(4):291-299. (PMID: 34623946) Blood. 2022 Jan 6;139(1):44-58. (PMID: 34525198) Circulation. 2018 Aug 14;138(7):666-668. (PMID: 30359133) Exp Gerontol. 2025 May;203:112729. (PMID: 40081680) Cochrane Database Syst Rev. 2012 Jan 18;1:CD008921. (PMID: 22258992) Reumatologia. 2025 Apr 14;63(2):97-103. (PMID: 40485943) Nat Rev Rheumatol. 2023 Apr;19(4):239-251. (PMID: 36801919) Immun Ageing. 2019 Nov 05;16:29. (PMID: 31708994) Arthritis Res Ther. 2025 Jan 3;27(1):2. (PMID: 39754234) Am Heart J. 2013 Oct;166(4):622-628.e1. (PMID: 24093840) Reumatologia. 2024;62(3):176-186. (PMID: 39055728) Eur J Clin Nutr. 2025 Sep;79(9):888-896. (PMID: 40335749) Ann Rheum Dis. 2026 Feb;85(2):235-237. (PMID: 40750565) Front Med (Lausanne). 2025 Apr 28;12:1555089. (PMID: 40357289) Reumatol Clin (Engl Ed). 2022 Oct;18(8):453-458. (PMID: 34893459) Rheumatol Int. 2017 Jun;37(6):1021-1026. (PMID: 28286904) Ageing Res Rev. 2021 Nov;71:101422. (PMID: 34391943) Clin Lymphoma Myeloma. 2008 Apr;8(2):87-93. (PMID: 18501101) |
| Grant Information: | TKP2021-NKTA-47 Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; TKP2021-EGA-29 Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; National Cardiovascular Laboratory Program (RRF-2.3.1-21-2022-00003) Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; the EKÖP-2024-9 New National Excellence Program of the Ministry for Culture Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Innovation Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; 101004093/ EUniWell/EAC-A02-2019 / EAC-A02-2019-1 European University for Well-Being |
| Contributed Indexing: | Keywords: Age-related immune dysfunction; Aging; Biological aging; Difficult-to-treat rheumatoid arthritis; Elderly-onset rheumatoid arthritis; Frailty; Immunosenescence; Inflammaging; Multimorbidity; Personalized therapeutics; Polypharmacy; Precision medicine; Therapeutic resistance; Unhealthy aging |
| Substance Nomenclature: | 0 (Antirheumatic Agents) |
| Entry Date(s): | Date Created: 20251226 Date Completed: 20260309 Latest Revision: 20260926 |
| Update Code: | 20260926 |
| PubMed Central ID: | PMC12972182 |
| DOI: | 10.1007/s11357-025-02049-y |
| PMID: | 41454175 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 2509-2723 |
|---|---|
| DOI: | 10.1007/s11357-025-02049-y |